MAPT and Alzheimer disease: Neurofibrillary tangles are another pathological feature of AD patients, besides, phosphorylated tau aggregates proteins to cause neuron damage, and drugs targeting tau are promising for AD therapy (Brier et al., 2016; Gauthier et al., 2016; Li and Gotz, 2017; Novak et al., 2017).